A detailed history of Jane Street Group, LLC transactions in En V Veno Medical Corp stock. As of the latest transaction made, Jane Street Group, LLC holds 71,771 shares of NVNO stock, worth $30,143. This represents 0.0% of its overall portfolio holdings.

Number of Shares
71,771
Previous 12,833 459.27%
Holding current value
$30,143
Previous $51,000 25.49%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$0.72 - $5.25 $42,435 - $309,424
58,938 Added 459.27%
71,771 $64,000
Q2 2025

Aug 14, 2025

BUY
$2.12 - $4.49 $27,205 - $57,620
12,833 New
12,833 $51,000
Q4 2024

Feb 14, 2025

BUY
$2.49 - $3.65 $46,069 - $67,532
18,502 New
18,502 $54,000
Q1 2024

May 15, 2024

BUY
$3.94 - $6.65 $99,733 - $168,331
25,313 New
25,313 $137,000

Others Institutions Holding NVNO

About enVVeno Medical Corp


  • Ticker NVNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 9,469,850
  • Market Cap $3.98M
  • Description
  • enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...
More about NVNO
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.